Fischer Medical Ventures Limited (FISCHER) — Board Meeting | 12 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approves conversion of 66,31,664 warrants into equity shares.
🔄 What Changed
Rs. 11.64 crore received from warrant conversion.
💡 Investor Takeaway
The conversion raises capital and dilutes promoter holdings through new equity issuance.

Fischer Medical Ventures Limited announced the board's approval on August 12, 2026, to convert 66,31,664 convertible warrants into equity shares at Rs. 23.40 per share, generating Rs. 11.64 crore from cash payments covering 75% of the exercise price. The allotment includes promoter Mr. Shankar Varadharajan and FMV Holdings Pte Ltd.

📄 View Original Announcement (PDF)

About Fischer Medical Ventures Limited (FISCHER)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹2,261.37 Cr P/E: 59.0

View full FISCHER stock details →

📡 Get AI alerts when FISCHER files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FISCHER — Free

📊 More FISCHER filings

See all FISCHER filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FISCHER files new disclosures

Track FISCHER filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FISCHER — Free

Free account · 2 AI queries/day